|
positive regulation of protein import into nucleus
|
GO_0042307 |
[Any process that activates or increases the frequency, rate or extent of movement of proteins from the cytoplasm into the nucleus.] |
|
negative regulation of septum digestion after cytokinesis
|
GO_2001042 |
[Any process that stops, prevents or reduces the frequency, rate or extent of the process of physically separating the septal cell wall material by enzymatic digestion, that occurs after daughter cells are separated by cytokinesis.] |
|
specification of segmental identity, mandibular segment
|
GO_0042305 |
[The specification of the characteristic structures of the mandibular segment following establishment of segment boundaries. Identity is considered to be the aggregate of characteristics by which a structure is recognized.] |
|
GO_2001048
|
GO_2001048 |
|
|
mitochondrial respiratory chain complex I assembly
|
GO_0032981 |
[The aggregation, arrangement and bonding together of a set of components to form mitochondrial respiratory chain complex I.] |
|
GO_2001047
|
GO_2001047 |
|
|
positive regulation of integrin-mediated signaling pathway
|
GO_2001046 |
[Any process that activates or increases the frequency, rate or extent of integrin-mediated signaling pathway.] |
|
kainate selective glutamate receptor complex
|
GO_0032983 |
[An assembly of four or five subunits which form a structure with an extracellular N-terminus and a large loop that together form the ligand binding domain. The C-terminus is intracellular. The ionotropic glutamate receptor complex itself acts as a ligand gated ion channel; on binding glutamate, charged ions pass through a channel in the center of the receptor complex. Kainate receptors are multimeric assemblies of GluK1-3 (also called GluR5-7), GluK4 (KA1) and GluK5 (KA2) subunits.] |
|
GO_2001041
|
GO_2001041 |
|
|
positive regulation of cellular response to drug
|
GO_2001040 |
[Any process that activates or increases the frequency, rate or extent of cellular response to drug.] |
|
positive regulation of response to drug
|
GO_2001025 |
[Any process that activates or increases the frequency, rate or extent of response to drug.] |
|
phosphate ion binding
|
GO_0042301 |
[Binding to a phosphate ion.] |
|
beta-amyrin synthase activity
|
GO_0042300 |
[Catalysis of the reaction: (S)-2,3-epoxysqualene = beta-amyrin.] |
|
protein-carbohydrate complex disassembly
|
GO_0032985 |
[The disaggregation of a protein-carbohydrate complex into its constituent components.] |
|
cellular anatomical entity morphogenesis
|
GO_0032989 |
[The process in which a cellular entity is generated and organized. A cellular entity has granularity above the level of a protein complex but below that of an anatomical system.] |
|
positive regulation of plant-type cell wall cellulose biosynthetic process
|
GO_2001011 |
[Any process that activates or increases the frequency, rate or extent of plant-type cell wall cellulose biosynthetic process.] |
|
regulation of plant-type cell wall cellulose biosynthetic process
|
GO_2001009 |
[Any process that modulates the frequency, rate or extent of plant-type cell wall cellulose biosynthetic process.] |
|
positive regulation of cellulose biosynthetic process
|
GO_2001008 |
[Any process that activates or increases the frequency, rate or extent of cellulose biosynthetic process.] |
|
negative regulation of plant-type cell wall cellulose biosynthetic process
|
GO_2001010 |
[Any process that stops, prevents or reduces the frequency, rate or extent of plant-type cell wall cellulose biosynthetic process.] |
|
negative regulation of cellulose biosynthetic process
|
GO_2001007 |
[Any process that stops, prevents or reduces the frequency, rate or extent of cellulose biosynthetic process.] |